Skip to content

Adjunctive Family CBT for Veterans With Anxiety

Increasing the Effectiveness of CBT for Anxiety in Veterans by Involving Family Members.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05340478
Acronym
AF-CBT
Enrollment
48
Registered
2022-04-22
Start date
2022-09-01
Completion date
2024-04-30
Last updated
2025-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorder

Keywords

panic, generalized anxiety, social anxiety, CBT

Brief summary

Despite the prevalence of posttraumatic stress disorder and anxiety disorders among Veterans, there has been limited focus on the development of interventions that include family members in treatments provided to Veterans. This is a feasibility study that examines a novel adjunct intervention (Adjunctive Family-Cognitive Behavioral Therapy; AF-CBT) developed for family members of Veterans undergoing behavioral treatment for anxiety-based disorders. Phase one involves piloting AF-CBT with family members and conducting qualitative interviews to obtain feedback about the utility and acceptability of the intervention. The refined protocol will be used in phase two, which involves an open trial where Veterans and family members will complete the intervention and attend a 1-month follow up assessment, including a qualitative interview.

Detailed description

Posttraumatic stress disorder (PTSD) and anxiety disorders such as panic, generalized and social anxiety are highly prevalent among Veterans of all eras and negatively impact functioning and quality of life. Avoidance is a hallmark feature of anxiety and functions to maintain the disorder. Although cognitive behavior therapy (CBT) is effective, a significant proportion of Veterans show minimal improvement following treatment. This is often due to poor treatment adherence such as avoidance of using skills taught in CBT that require confronting distressing memories and feared situations. Avoidance behavior also can extend to caregivers and family members of Veterans, who may engage in accommodation behaviors (i.e., changing their own behaviors) to help alleviate distress experienced by their loved ones. As such, accommodation by family members undermines the effectiveness of CBT and is associated with greater symptom severity and functional impairment in persons with anxiety. This study will examine the feasibility, acceptability, and satisfaction associated with a new intervention for family members of Veterans undergoing CBT for anxiety-based disorders. Adjunctive Family-CBT (AF-CBT) provides family members psychoeducation on anxiety and teaches skills that can be used to facilitate the recovery of Veterans who are in the process of completing treatment for anxiety. Aims of the study are to: (1) adapt and refine AF-CBT through an iterative process that will be informed by feedback from Veterans and family members; (2) examine the feasibility and acceptability/satisfaction of AF-CBT; (3) assess the validity and reliability of the Family Accommodation Scale-Anxiety adapted for Veterans and family members; and (4) examine the associations between family accommodation behavior and readjustment and anxiety in Veterans. The proposed study involves a total of 47 Veterans and family member dyads (V/F dyad) and will be conducted in two phases. In phase 1, 12 V/F dyads will be recruited, and family members will receive AF-CBT while the Veteran undergoes iCBT for anxiety. The intervention will be delivered in three separate cohorts (approximately 4 V/F dyad in each cohort). During the 1-month assessment, information obtained from qualitative interviews will be used to refine the intervention in an iterative process with each cohort. In phase 2, 35 V/F dyads will be recruited and administered the finalized version of AF-CBT following the same treatment and assessment format. Qualitative interviews will focus on each V/F dyad's experience with the AF-CBT intervention and whether specific components of the intervention facilitated the Veteran's recovery process.

Interventions

BEHAVIORALAdjunctive Family - Cognitive Behavioral Therapy

AF-CBT provides family members psychoeducation on anxiety and teaches skills to facilitate the recovery of Veterans in the process of completing anxiety treatment.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Pilot feasibility trial with 2 phases. Phase 1 involved adapting and refining the AF-CBT intervention. Phase 2 involved a small pilot to assess feasibility of delivering the AF-CBT intervention.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Veteran at least 18 years old; * current diagnosis of at least one anxiety-based disorder: PTSD, PD, SAD, or GAD (based on ADIS-5); * moderate-to-poor life enjoyment and satisfaction as indicated by a score of 47 or lower on the Q-LES-Q-SF * BAI score of 16 (moderate anxiety) or higher; * stable on psychotropic medication for 4 weeks before study participation; and * has a family member willing to participate in the study

Exclusion criteria

* Active symptoms of mania or psychosis at baseline (based on ADIS-5); * depression with active suicidal ideation/intent that would preclude treatment (based on ADIS-5 & BAI); * moderate-to-severe cognitive impairment as indicated by a score below 20 on the SLUMS; * active drug/alcohol abuse during the initial 3-months of study enrollment (otherwise Veterans with comorbid substance/alcohol dependence are study eligible); and * undergoing concurrent transdiagnostic CBT for anxiety.

Design outcomes

Primary

MeasureTime frameDescription
Modified Treatment Evaluation Inventory1-month follow-upDegree to which treatment components were found to be acceptable. Scores range from 9-45, with higher scores reflecting greater acceptance of treatment.
Client Satisfaction Questionnaire1-month follow-upDegree to which participant was satisfied with treatment. Scores range from 8-32, with higher scores reflecting greater satisfaction.
Feasibility of Recruitment for AF-CBTRecruitment Initiation to Recruitment Completion (up to 18 Months)This outcome pertains to the feasibility of recruiting participant dyads for the AF-CBT intervention across Phases 1 and 2 of the study. The rate of recruitment is based on the number of dyads who agreed to participate out of those invited during the active recruitment period for this study.
Feasibility of Retention for AF-CBTBaseline to Treatment Completion (average 4 months)This outcome pertains to the feasibility of retaining participant dyads for the AF-CBT intervention across Phases 1 and 2 of the study. The rate of retention is the percentage of dyads who complete AF-CBT by attending all sessions.

Secondary

MeasureTime frameDescription
Beck Anxiety InventoryBaseline; 1-Month Follow-UpMeasure of anxiety including cognitive and somatic components of anxiety. Scores range from 0-63, with higher scores reflecting higher levels of anxiety. Note: The BAI was not collected from family members.
Family Accommodation ScaleBaseline; 1-Month Follow-UpDegree to which family member engages in accommodation behaviors. Scores range from 0-36, with higher scores reflecting greater levels of accommodation.

Countries

United States

Participant flow

Recruitment details

Study recruitment occurred from Sept 2022 - Mar 2024 at the Michael E. DeBakey VA Medical Center.

Pre-assignment details

There were a total of 7 dyads (14 participants comprised of 7 Veterans & 7 Family members) who were excluded after consenting (6 dyads did not meet inclusion criteria; 1 dyad was not clinically appropriate for the study).

Participants by arm

ArmCount
Phase 1 (Initial) - Adapt/Refine AF-CBT
Adjunctive Family - Cognitive Behavioral Therapy (AF-CBT) was adapted and refined for family members of Veterans with anxiety using an iterative process during Phase 1.
16
Phase 2 (Final) - Pilot AF-CBT
The final version of Adjunctive Family - Cognitive Behavioral Therapy (AF-CBT) was delivered to family members of Veterans with anxiety during Phase 2.
42
Total58

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up14
Overall StudyNeither member of dyad started treatment22
Overall StudyScheduling Issues104
Overall StudyWithdrawn from study22

Baseline characteristics

CharacteristicPhase 1 (Initial) - Adapt/Refine AF-CBTPhase 2 (Final) - Pilot AF-CBTTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants0 Participants1 Participants
Age, Categorical
Between 18 and 65 years
7 Participants21 Participants28 Participants
Age, Continuous48.13 years
STANDARD_DEVIATION 13.35
45.62 years
STANDARD_DEVIATION 11.47
46.31 years
STANDARD_DEVIATION 11.82
Ethnicity (NIH/OMB)
Family Members
Hispanic or Latino
3 Participants8 Participants11 Participants
Ethnicity (NIH/OMB)
Family Members
Not Hispanic or Latino
5 Participants12 Participants17 Participants
Ethnicity (NIH/OMB)
Family Members
Unknown or Not Reported
0 Participants1 Participants1 Participants
Ethnicity (NIH/OMB)
Veterans
Hispanic or Latino
1 Participants6 Participants7 Participants
Ethnicity (NIH/OMB)
Veterans
Not Hispanic or Latino
7 Participants15 Participants22 Participants
Ethnicity (NIH/OMB)
Veterans
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Family Member
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Family Member
Asian
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Family Member
Black or African American
1 Participants3 Participants4 Participants
Race (NIH/OMB)
Family Member
More than one race
0 Participants5 Participants5 Participants
Race (NIH/OMB)
Family Member
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Family Member
Unknown or Not Reported
1 Participants3 Participants4 Participants
Race (NIH/OMB)
Family Member
White
5 Participants10 Participants15 Participants
Race (NIH/OMB)
Veteran
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Veteran
Asian
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Veteran
Black or African American
0 Participants3 Participants3 Participants
Race (NIH/OMB)
Veteran
More than one race
3 Participants1 Participants4 Participants
Race (NIH/OMB)
Veteran
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Veteran
Unknown or Not Reported
0 Participants2 Participants2 Participants
Race (NIH/OMB)
Veteran
White
4 Participants15 Participants19 Participants
Region of Enrollment
United States
16 Participants42 Participants58 Participants
Sex: Female, Male
Family Members
Female
7 Participants16 Participants23 Participants
Sex: Female, Male
Family Members
Male
1 Participants5 Participants6 Participants
Sex: Female, Male
Veterans
Female
1 Participants4 Participants5 Participants
Sex: Female, Male
Veterans
Male
7 Participants17 Participants24 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 21
other
Total, other adverse events
0 / 82 / 21
serious
Total, serious adverse events
0 / 80 / 21

Outcome results

Primary

Client Satisfaction Questionnaire

Degree to which participant was satisfied with treatment. Scores range from 8-32, with higher scores reflecting greater satisfaction.

Time frame: 1-month follow-up

Population: In Phase 1, 1 family member did not complete this measure. In Phase 2, 1 Veteran and 2 Family Members did not complete this measure.

ArmMeasureGroupValue (MEAN)Dispersion
Phase 1 (Initial) - Adapt/Refine AF-CBTClient Satisfaction QuestionnaireVeteran26.63 score on a scaleStandard Deviation 3.16
Phase 1 (Initial) - Adapt/Refine AF-CBTClient Satisfaction QuestionnaireFamily Member27.00 score on a scaleStandard Deviation 3.16
Phase 2 (Final) - Pilot AF-CBTClient Satisfaction QuestionnaireVeteran28.60 score on a scaleStandard Deviation 3.62
Phase 2 (Final) - Pilot AF-CBTClient Satisfaction QuestionnaireFamily Member28.42 score on a scaleStandard Deviation 3.66
Primary

Feasibility of Recruitment for AF-CBT

This outcome pertains to the feasibility of recruiting participant dyads for the AF-CBT intervention across Phases 1 and 2 of the study. The rate of recruitment is based on the number of dyads who agreed to participate out of those invited during the active recruitment period for this study.

Time frame: Recruitment Initiation to Recruitment Completion (up to 18 Months)

Population: A total of 64 dyads (Veterans \& Family Members) were invited to participate in the study.

ArmMeasureValue (NUMBER)
Phase 1 (Initial) - Adapt/Refine AF-CBTFeasibility of Recruitment for AF-CBT48 dyads
Primary

Feasibility of Retention for AF-CBT

This outcome pertains to the feasibility of retaining participant dyads for the AF-CBT intervention across Phases 1 and 2 of the study. The rate of retention is the percentage of dyads who complete AF-CBT by attending all sessions.

Time frame: Baseline to Treatment Completion (average 4 months)

Population: In Phase 1, of the 30 participants (Veterans \& Family Members) enrolled, 15 completed treatment. In Phase 2, of the 52 participants (Veterans \& Family Members) enrolled, 39 completed treatment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Phase 1 (Initial) - Adapt/Refine AF-CBTFeasibility of Retention for AF-CBT15 Participants
Phase 2 (Final) - Pilot AF-CBTFeasibility of Retention for AF-CBT39 Participants
Primary

Modified Treatment Evaluation Inventory

Degree to which treatment components were found to be acceptable. Scores range from 9-45, with higher scores reflecting greater acceptance of treatment.

Time frame: 1-month follow-up

Population: In Phase 1, 1 family member did not complete this measure. In Phase 2, 1 Veteran and 2 Family Members did not complete this measure.

ArmMeasureGroupValue (MEAN)Dispersion
Phase 1 (Initial) - Adapt/Refine AF-CBTModified Treatment Evaluation InventoryVeteran32.13 score on a scaleStandard Deviation 3.31
Phase 1 (Initial) - Adapt/Refine AF-CBTModified Treatment Evaluation InventoryFamily Member34.29 score on a scaleStandard Deviation 4.07
Phase 2 (Final) - Pilot AF-CBTModified Treatment Evaluation InventoryVeteran35.40 score on a scaleStandard Deviation 5.11
Phase 2 (Final) - Pilot AF-CBTModified Treatment Evaluation InventoryFamily Member35.32 score on a scaleStandard Deviation 4.73
Secondary

Beck Anxiety Inventory

Measure of anxiety including cognitive and somatic components of anxiety. Scores range from 0-63, with higher scores reflecting higher levels of anxiety. Note: The BAI was not collected from family members.

Time frame: Baseline; 1-Month Follow-Up

Population: One Veteran in Phase 2 did not complete the BAI at the 1-Month Follow-Up.

ArmMeasureGroupValue (MEAN)Dispersion
Phase 1 (Initial) - Adapt/Refine AF-CBTBeck Anxiety InventoryBaseline Veteran35.00 score on a scaleStandard Deviation 11.2
Phase 1 (Initial) - Adapt/Refine AF-CBTBeck Anxiety Inventory1 Month Veteran31.25 score on a scaleStandard Deviation 17.25
Phase 2 (Final) - Pilot AF-CBTBeck Anxiety InventoryBaseline Veteran32.62 score on a scaleStandard Deviation 11.74
Phase 2 (Final) - Pilot AF-CBTBeck Anxiety Inventory1 Month Veteran19.20 score on a scaleStandard Deviation 12.63
p-value: <0.001t-test, 2 sided
Secondary

Family Accommodation Scale

Degree to which family member engages in accommodation behaviors. Scores range from 0-36, with higher scores reflecting greater levels of accommodation.

Time frame: Baseline; 1-Month Follow-Up

Population: In Phase 1, 1 family member did not complete this measure at the 1-month follow-up. In Phase 2, 1 Veteran and 2 Family Members did not complete this measure at the 1-month follow-up.

ArmMeasureGroupValue (MEAN)Dispersion
Phase 1 (Initial) - Adapt/Refine AF-CBTFamily Accommodation ScaleBaseline Family Member21.75 units on a scaleStandard Deviation 8.45
Phase 1 (Initial) - Adapt/Refine AF-CBTFamily Accommodation ScaleBaseline Veteran20.50 units on a scaleStandard Deviation 9.07
Phase 1 (Initial) - Adapt/Refine AF-CBTFamily Accommodation Scale1 Month Family Member25.00 units on a scaleStandard Deviation 7.83
Phase 1 (Initial) - Adapt/Refine AF-CBTFamily Accommodation Scale1 Month Veteran19.75 units on a scaleStandard Deviation 8.14
Phase 2 (Final) - Pilot AF-CBTFamily Accommodation Scale1 Month Family Member15.05 units on a scaleStandard Deviation 7.6
Phase 2 (Final) - Pilot AF-CBTFamily Accommodation ScaleBaseline Family Member19.86 units on a scaleStandard Deviation 8.51
Phase 2 (Final) - Pilot AF-CBTFamily Accommodation Scale1 Month Veteran18.00 units on a scaleStandard Deviation 9.41
Phase 2 (Final) - Pilot AF-CBTFamily Accommodation ScaleBaseline Veteran19.62 units on a scaleStandard Deviation 9.21

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026